Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals
about
Potential drug-drug interactions in Alzheimer patients with behavioral symptomsPolypharmacy in Older Adults With Hypertension: A Comprehensive ReviewCoordinated changes in xenobiotic metabolizing enzyme gene expression in aging male rats.Domoic acid as a developmental neurotoxin.Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.Association of markers of chronic viral hepatitis and blood mercury levels in US reproductive-age women from NHANES 2001-2008: a cross-sectional study.Dispelling urban myths about default uncertainty factors in chemical risk assessment--sufficient protection against mixture effects?Potential new approaches for children's inhalation risk assessment.Distributional analyses for children's inhalation risk assessments.Patient variation in veterinary medicine--part II--influence of physiological variables.Polypharmacy and food-drug interactions among older persons: a review.Alterations in drug disposition in older adults.Impact of renal aging on drug therapy.New, Occasional, and Frequent Use of Zolpidem or Zopiclone (Alone and in Combination) and the Risk of Injurious Road Traffic Crashes in Older Adult Drivers: A Population-Based Case-Control and Case-Crossover Study.Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.Pharmacokinetic and pharmacodynamic alterations in older people with dementia.Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing.
P2860
Q26782490-4A938E81-0241-48A5-A3E1-423799836AEBQ26799236-E2B76FA4-7B18-4DE1-A3DA-A46E5FA53823Q29347030-4EB851A7-C7A2-4489-8D15-942DEB4A2119Q30474393-AFA0AB64-D23E-4B21-B01C-A64A1EEC5C15Q33396717-AE69C63F-8A9E-42B7-B358-312C79D9B50AQ36439086-DBD5C1CE-5836-4453-9737-95A860879680Q37004073-8EDCA198-686C-4109-879F-8C02D38E52EEQ37039751-E01A8E59-3061-4792-BE2F-CC6FA18A52A8Q37039756-C7513CEF-37D5-418C-AE61-76C9FDAC9775Q37810325-B2E99299-9212-4A74-A442-1AD9087B85F9Q38060181-C90970A6-92D3-43DC-A34C-559E3B412EB7Q38323527-6179C949-2F39-4E30-B418-94722FB0CD24Q38544072-672ECE23-6629-4B75-8E4E-EDBC3DF34625Q38698209-5E2DD7DE-86F5-4BCA-8ECC-D61EABE2BD0DQ38817753-1030733B-E968-49BE-8FE5-07B66C0F93EBQ39275819-9C438D7B-9EC8-4C59-97F8-DB847CA56E04Q42001999-CE8CE63B-A6E6-4470-9E33-DC0B77A1F690
P2860
Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@ast
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@en
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@nl
type
label
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@ast
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@en
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@nl
prefLabel
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@ast
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@en
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@nl
P2093
P2860
P921
P356
P1476
Pharmacokinetic and pharmacody ...... equelae in elderly individuals
@en
P2093
Babasaheb Sonawane
Dale Hattis
Gary Ginsberg
P2860
P304
P356
10.1289/EHP.7568
P407
P5008
P577
2005-09-01T00:00:00Z